Laakso M, Pentikäinen P J, Rehnberg S
Int J Clin Pharmacol Ther Toxicol. 1984 Sep;22(9):487-90.
A case history is reported of a patient who had several episodes of unconsciousness (because of ventricular extrasystole) while on antiarrhythmic and antihypertensive therapy consisting of quinidine (200 mg b. i. d.), sotalol (80 mg b. i. d.) and hydrochlorothiazide (50 mg g. d.). The syncopal attacks continued after discontinuation of quinidine but ended when sotalol was replaced by metoprolol and later on by verapamil. Marked prolongation of the previously normal Q-Tc interval (up to 0.71 s) was observed during the therapy with sotalol alone or combined with quinidine. The syncopal attacks were preceded by feeling of cardiac arrhythmia and they were most likely caused by torsade de pointes tachycardia. The prolongation of the Q-Tc interval by sotalol alone or combined with quinidine was obviously related to the tendency to cardiac arrhythmia and consequent episodes of unconsciousness.
报告了一例患者的病史,该患者在接受由奎尼丁(200毫克,每日两次)、索他洛尔(80毫克,每日两次)和氢氯噻嗪(50毫克,每日一次)组成的抗心律失常和抗高血压治疗期间,因室性早搏出现了几次意识丧失发作。停用奎尼丁后晕厥发作仍持续,但当索他洛尔被美托洛尔取代,随后又被维拉帕米取代时,发作结束。在单独使用索他洛尔或与奎尼丁联合治疗期间,观察到先前正常的Q-Tc间期明显延长(长达0.71秒)。晕厥发作前有心律失常的感觉,最可能是由尖端扭转型室性心动过速引起的。单独使用索他洛尔或与奎尼丁联合使用导致的Q-Tc间期延长显然与心律失常倾向及随之而来的意识丧失发作有关。